GL1X · GenesisL1 explorer

MolNFT v1 · #74214 · protein

Structure of a CRISPR associated protein CAS2 from desulfovibrio vulgaris

3OQ2 · CRISPR-associated protein CAS2: “Structure of a CRISPR associated protein CAS2 from desulfovibrio vulgaris”. X-ray diffraction, 3 ligands (NA, SO4, CL), 1 pocket (best druggability 0.43). MolNFT v1 #74214 on GenesisL1: 3D structure…

PDB
3OQ2
Type
protein
Length
201 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CRISPR-associated protein CAS2
UniProt
Q72WF4
Ligands
NA, SO4, CL
Pockets
1 · best druggability 0.43

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACRISPR-associated protein CAS2protein9935% helix, 32% strandQ72WF4
BCRISPR-associated protein CAS2protein10230% helix, 31% strandQ72WF4

Ligands and binding sites

  • NA · Sodium ion · metal · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B
  • CL · Chloride ion · ion · chains A
  • CIT · Citric acid · additive · 3 copies · chains A, B
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11460.430.7524empty

Interfaces

1 interface between chains.

  • A–B · 1404 Ų buried · 39 hydrogen bonds · protein-protein

Compared structures

  • 3OQ2 · Structure of a CRISPR associated protein Cas2 from Desulfovibrio vulgaris · the same entry in another collection · chain A against A, TM-score 1.00
  • Q72WF4 · AlphaFold monomer V2.0 prediction for CRISPR-associated endoribonuclease CAS2 (Q72WF4) · a predicted model of the same protein · chain B against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.